A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00802594
Recruitment Status : Completed
First Posted : December 5, 2008
Last Update Posted : December 5, 2008
Bill and Melinda Gates Foundation
Information provided by:
Immtech Pharmaceuticals, Inc